Category
6 products in GLP-1 Agonists · Third-party tested · COA available
Research peptides and oral small molecules targeting the GLP-1 receptor (and related incretin pathways including GIP and glucagon). Includes Semaglutide, Tirzepatide, Retatrutide, and the oral agonist Orforglipron — used in studies of glucose homeostasis, appetite regulation, and metabolic signaling.
Research Use Only. All compounds listed are intended solely for in vitro research and laboratory use. Not for human or veterinary use. Not for consumption. By purchasing, you confirm you are a qualified researcher and agree to our terms of service.